Within advanced therapy manufacturing, more and more companies are turning to enzymatically produced DNA as an alternative to plasmid DNA.
Read More
Touchlight Appoints Industry Leader Will Downie as Adviser to Support Strategic Growth in Synthetic DNA Platforms Published: 27 January 2025 Touchlight Genetics, in partnership with the National Physical Laboratory (NPL)…
Read More
Ceva Animal Health and Touchlight sign an agreement to use Touchlight’s dbDNA technology in animal health Published: 16 January 2025 Ceva and Touchlight entered into an agreement and a long-term…
Read More
Touchlight’s dbDNA™ manufacturing facility receives world-first GMP license from MHRA Published: 14 January 2025 Touchlight’s dbDNA technology is the first synthetic DNA technology to receive a GMP certificate globally Touchlight…
Read More
As advanced therapies continue to transform the healthcare landscape, the need for sustainable manufacturing solutions grows more critical. Traditional plasmid DNA (pDNA) production presents costly, resource-intensive challenges, threatening scalability and…
Read More
Rewriting the Rules of Gene Therapy with Nonviral DNA Delivery Published: 14 November 2024 Lisa Caproni, Ph.D. As gene therapy continues to evolve, nonviral DNA delivery is rapidly gaining traction…
Read More
ELENA STOYANOVA, PH.D. & TOM ADIE, PH.D. Touchlight is at the forefront of innovation in gene editing technology with our groundbreaking MegaBulb DNA (mbDNA). This novel, circular, single-stranded DNA template…
Read More
Touchlight to supply GMP dbDNA to support University of Nottingham’s clinical study for a next-generation vaccine for Zika virus Published: 21 August 2024 Touchlight, an innovation-driven contract development and manufacturing…
Read More
Touchlight and GSK sign license agreement for use of enzymatic dbDNA production technology for mRNA manufacturing Published: 23 July 2024 Agreement enables GSK access to enzymatic production technology for rapid…
Read More
Touchlight is pioneering the next generation of DNA manufacturing with our transformative dbDNA™ technology. The enzymatic DNA manufacturing platform sets new industry standards for speed, purity, and scalability, overcoming the…
Read More
